Follicular hyperplasia on the face subsequent to therapy with sorafenib. A new skin side effect

J Eur Acad Dermatol Venereol. 2009 Aug;23(8):959-60. doi: 10.1111/j.1468-3083.2008.03003.x. Epub 2008 Sep 10.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged, 80 and over
  • Antineoplastic Agents / adverse effects*
  • Antineoplastic Agents / therapeutic use
  • Benzenesulfonates / adverse effects*
  • Benzenesulfonates / therapeutic use
  • Humans
  • Hyperplasia / chemically induced
  • Hyperplasia / diagnosis
  • Lung Neoplasms / drug therapy
  • Lung Neoplasms / secondary
  • Male
  • Melanoma / drug therapy
  • Melanoma / secondary
  • Niacinamide / analogs & derivatives
  • Nitrosourea Compounds / therapeutic use
  • Organophosphorus Compounds / therapeutic use
  • Phenylurea Compounds
  • Pyridines / adverse effects*
  • Pyridines / therapeutic use
  • Skin / pathology*
  • Skin Diseases / chemically induced*
  • Skin Diseases / diagnosis
  • Skin Neoplasms / pathology
  • Sorafenib

Substances

  • Antineoplastic Agents
  • Benzenesulfonates
  • Nitrosourea Compounds
  • Organophosphorus Compounds
  • Phenylurea Compounds
  • Pyridines
  • Niacinamide
  • Sorafenib
  • fotemustine